Reunion Neuroscience Puts in Place At-The-Market Equity Facility

November 19, 2022

https://www.globenewswire.com/news-release/2022/11/18/2559438/0/en/Reunion-Neuroscience-Puts-in-Place-At-The-Market-Equity-Facility.html

TORONTO, Nov. 18, 2022 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (TSX:REUN, NASDAQ:REUN) (“Reunion” or the “Company”), a biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions, today announced that it has entered into an equity distribution agreement with Canaccord Genuity to establish an at-the-market equity facility.

Read more at globenewswire.com

Related news for (REUN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.